Acute Clinical Outcomes of Hemorrhagic Myocardial Infarction

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06110351

Acronym

MIRON-ACUTE

Enrollment

12000

Registered

2023-10-31

Start date

2023-11-08

Completion date

2024-12-15

Last updated

2025-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Brief summary

Acute clinical outcomes 1. Mortality 2. Arrhythmia 3. Readmission 4. CVA 5. ADHF

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

1. 18-85 years of age 2. Primary PCI 3. Post-PCI cardiac biomarker labs

Design outcomes

Primary

Measure	Time frame	Description
Mortality	30-days and 6 months	Prevalence of acute mortality

Secondary

Measure	Time frame	Description
Acute heart failure	30-days and 6 months	Prevalence of acute heart failure
Arrhythmia	30-days and 6 months	Prevalence of acute arrhythmia

Countries

United States

Outcome results